{"schema_version":"secwatch.filing_event.v1","accession":"0000724004-25-000012","form_type":"8-K","ticker":"MLAB","cik":"0000724004","company_name":"MESA LABORATORIES INC /CO/","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.015830+00:00","generated_at":"2026-05-17T00:05:25.191872+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Mesa Labs 2Q26 revenue up 5%, net income down 27.8% on tariffs and China headwinds","bullets":["Total revenues $60.7M, +5.0% YoY; core organic growth 3.7%.","Net income $2.5M ($0.45 diluted EPS), down 27.8% from 2Q25.","Non-GAAP AOI excluding unusual items $15.2M, +6.1%; margin 25.1% vs 24.8%.","Clinical Genomics core organic -3.6%: China -58%; outside China +16.2%.","Annualized cost reductions of $3.2M; net savings $2.3M after reinvestment. Tariffs 70 bps of revenue."],"urls":{"canonical":"https://secwatch.observer/filing/0000724004-25-000012","json":"https://secwatch.observer/filing/0000724004-25-000012.json","markdown":"https://secwatch.observer/filing/0000724004-25-000012.md","text":"https://secwatch.observer/filing/0000724004-25-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/724004/000072400425000012/0000724004-25-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/724004/000072400425000012/mlab20251106_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:05:25.191872+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}